We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Predisposing Gene Associated With Cowden Syndrome

By LabMedica International staff writers
Posted on 15 Nov 2015
Print article
Image: Mucocutaneous papilloma manifestations around the nose of an autosomal dominant condition known as Cowden syndrome (Photo courtesy of University of Sao Paulo).
Image: Mucocutaneous papilloma manifestations around the nose of an autosomal dominant condition known as Cowden syndrome (Photo courtesy of University of Sao Paulo).
A new gene has been discovered that is associated with Cowden syndrome, an inherited condition that carries high risks of thyroid, breast, and other cancers, and a subset of non-inherited thyroid cancers.

Cowden syndrome (CS) is an underdiagnosed difficult-to-recognize autosomal-dominant disorder characterized by multiple hamartomas and an increased predisposition to breast, thyroid, endometrial, and other cancers and other non-neoplastic phenotypes that include macrocephaly and mucocutaneous findings.

Scientists at the Cleveland Clinic (Cleveland, OH, USA) and their colleagues subjected germline genomic DNA extracted from peripheral-blood leukocytes of the eligible proband to exome sequencing. Exome enrichment was performed, and subsequent 100 bp paired-end sequencing was performed with a HiSeq 2000 platform (Illumina, San Diego, CA, USA). Mutations in candidate genes of interest were validated by polymerase chain reaction (PCR)-based region-specific mutation analysis through Sanger sequencing. Sequencing was performed in the forward and reverse directions with ABI 3730xl DNA Analyzers (Applied Biosystems, Foster City, CA, USA).

Exome sequencing and targeted genotyping identified Sec23 homolog B, COPII coat complex component (SEC23B) as a candidate gene in a CS-affected family with predominant thyroid cancer. Further analyses uncovered that SEC23B mutations are present in up to 3% of unrelated Cowden syndrome patients and in 4% of patients with non-syndromic thyroid cancer. With up to 50% of Cowden syndrome patients testing negative for all known genetic mutations, the syndrome remains an under-diagnosed and difficult-to-recognize condition.

Patients with Cowden syndrome develop noncancerous growths, called hamartomas that can appear on the skin in mucous membranes and in the intestinal tract. Cowden syndrome predisposes individuals to several types of cancers, an 85% lifetime risk of breast cancer, a 35% risk for epithelial thyroid cancer, and increased risks of uterine, kidney and colon cancers as well. At least one in 200,000 people are affected by the disease.

Charis Eng, MD, PhD, the senior author of the study said, “This isn't the first time we discovered novel genetic mutations in Cowden syndrome, but what was truly remarkable is that the SEC23B gene had been identified back in 2009 as the cause of a very rare type of anemia, but not cancer. Our data not only identified a novel cancer-predisposing gene, particularly in thyroid cancer, but also highlighted how cellular stress responses can be hijacked by cancer cells to promote their survival.” The study was published on October 29, 2105 in the American Journal of Human Genetics.

Related Links:

Cleveland Clinic 
Illumina 
Applied Biosystems 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.